NDA 015921 · Ortho Mcneil
Haldol
Haloperidol · Oral
NovelPriority reviewDiscontinuedLast checked: Nov 20, 2026Latest source record: Apr 17, 2002 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1967
Apr 12, 1967
Approved uses
n/a
Original approval plus efficacy supplements
Registered trials
171
51 Phase 3, 4 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
No approvals could be loaded from Drugs@FDA just now.
Clinical trials
Interventional ClinicalTrials.gov studies with "Haloperidol" as an intervention, any sponsor and status, largest first.
Vanderbilt UniversityAcademic, hospital or other
NCT02625181 · 27,034 participants · Start Jul 2016 · Primary completion Nov 2, 2017
Drug: Propofol; Sevoflurane and 28 more · For: Postoperative Nausea and Vomiting
Sites: Nashville, Tennessee
- Metabolic Profile and Anthropometric Changes in SchizophreniaPivotal-lookingCompleted
Central Institute of Psychiatry, Ranchi, IndiaAcademic, hospital or other
NCT00534183 · 2,006 participants · Start Jun 2006
Drug: Olanzapine; Risperidone and 1 more · For: Metabolic Syndrome; Diabetes; Obesity
Sites: Ranchi, India
- pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for DeliriumPivotal-lookingCompleted
Radboud University Medical CenterAcademic, hospital or other
NCT01785290 · 1,800 participants · Start Jun 2013 · Primary completion Dec 2016
Drug: Haloperidol 1 mg/q8h; Haloperidol 2 mg/q8h and 1 more · For: Delirium
Sites: Nijmegen, Netherlands
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic SchizophreniaPivotal-lookingCompleted
Janssen, LPJohnson & Johnson (Janssen) (JNJ)
NCT00249119 · 1,579 participants
Drug: risperidone · For: Schizophrenia; Psychotic Disorder
- PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdelPivotal-lookingStatus unknown
Zuyderland Medisch CentrumAcademic, hospital or other
NCT03199950 · 1,366 participants (planned) · Start Jun 23, 2017 · Primary completion Nov 23, 2018
Drug: Haloperidol; Placebo Oral Tablet · For: Delirium
Sites: Sittard, Netherlands
- Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)Pivotal-lookingCompleted
Merck Sharp & Dohme LLCMerck & Co. (MRK)
NCT01594749 · 1,015 participants · Start Sep 24, 2012 · Primary completion Nov 3, 2014
Drug: Fosaprepitant dimeglumine; Fosaprepitant Placebo and 5 more · For: Chemotherapy-Induced Nausea and Vomiting (CINV)
- The Danish Out-of-Hospital Cardiac Arrest StudyPivotal-lookingActive, not recruiting
Christian HassagerAcademic, hospital or other
NCT05895838 · 1,000 participants (planned) · Start Jun 16, 2023 · Primary completion Sep 2027
Drug: Dexamethasone; Olanzapine · For: Out-Of-Hospital Cardiac Arrest; Post-Cardiac Arrest Syndrome
Sites: Copenhagen, Denmark; Aalborg, Denmark; Aarhus, Denmark · 5 sites in all
- Agents Intervening Against Delirium in Intensive Care UnitPivotal-lookingStatus unknown
Zealand University HospitalAcademic, hospital or other
NCT03392376 · 1,000 participants (planned) · Start Jun 13, 2018 · Primary completion Jul 9, 2022
Drug: Haloperidol Injection · For: Delirium
Sites: Aabenraa, Denmark; Aalborg, Denmark; Copenhagen, Denmark · 16 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Part B: Haldol* (Haloperidol Lactate*) · HCPCS J1630
2024 spending
$550
Beneficiaries
98
175 claims
Per beneficiary
$6
2024 ASP limit $1.22 per unit
View as table
| Year | Spending |
|---|---|
| 2020 | $498 |
| 2021 | $536 |
| 2022 | $548 |
| 2023 | $625 |
| 2024 | $550 |
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T, Ikuta T, Matsuda Y, et al. · Mol Psychiatry 2022 · Systematic Review, Research Support, Non-U.S. Gov't
- Haloperidol for the Treatment of Delirium in ICU Patients.
Andersen-Ranberg NC, Poulsen LM, Perner A, et al. · N Engl J Med 2022 · Multicenter Study, Randomized Controlled Trial
- Antipsychotics for delirium.
Lonergan E, Britton AM, Luxenberg J, et al. · Cochrane Database Syst Rev 2007 · Meta-Analysis, Systematic Review
- Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
Ruberto AJ, Sivilotti MLA, Forrester S, et al. · Ann Emerg Med 2021 · Randomized Controlled Trial
- Dosage of haloperidol for mania.
Rifkin A, Doddi S, Karajgi B, et al. · Br J Psychiatry 1994 · Clinical Trial, Comparative Study
- Haloperidol versus chlorpromazine for schizophrenia.
Leucht C, Kitzmantel M, Chua L, et al. · Cochrane Database Syst Rev 2008 · Meta-Analysis, Systematic Review
Sponsor: Johnson & Johnson (Janssen)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.